Cargando…
ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1
Lung cancer is the leading cause of death among all malignancies due to rapid tumor progression and relapse; however, the underlying molecular mechanisms of tumor progression are unclear. In the present study, we identified ANKRD22 as a novel tumor-associated gene in non-small cell lung cancer (NSCL...
Autores principales: | Yin, Jun, Fu, Wenfan, Dai, Lu, Jiang, Zeyong, Liao, Hongying, Chen, Wenbin, Pan, Lei, Zhao, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493668/ https://www.ncbi.nlm.nih.gov/pubmed/28667340 http://dx.doi.org/10.1038/s41598-017-04818-y |
Ejemplares similares
-
ANKRD22 is involved in the progression of prostate cancer
por: Qiu, Yiqing, et al.
Publicado: (2019) -
The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer
por: Zhao, Jian, et al.
Publicado: (2015) -
let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer
por: Yin, Jun, et al.
Publicado: (2019) -
HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
por: Yin, Jun, et al.
Publicado: (2019) -
Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin-resistant non-small cell lung cancer
por: Zhao, Jian, et al.
Publicado: (2020)